Hidroquinona: vilã ou heroína?

Hidroquinona: vilã ou heroína?

A hidroquinona é usada como agente clareador há mais de 50 anos, e, nos últimos 20, suas segurança e toxicidade têm sido questionadas. Nesta revisão bibliográfica, pode-se verificar que seu potencial carcinogênico e mutagênico não foi comprovado até hoje em humanos. Além d...

Full description

Bibliographic Details
Main Author:	Leandra d’Orsi Metsavaht
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Dermatologia (SBD) 2017-07-01
Series:	Surgical & Cosmetic Dermatology
Subjects:	hidroquinona toxicidade melasma segurança
Online Access:	http://www.surgicalcosmetic.org.br/detalhe-artigo/580/Hidroquinona--vila-ou-heroina-

Similar Items

Verificação do prazo de validade de cremes contendo hidroquinona preparados magistralmente: evidências do processo de oxidação
by: F.P. Kato, et al.
Published: (2010-05-01)

Use of helium-neon laser in patients with melasma
by: Ana Lucía Jacas Portuondo, et al.
Published: (2023-02-01)

Estudo duplo cego comparativo entre hidroquinona e extrato de uva-ursina no tratamento do melasma
by: Andréia Mateus Moreira, et al.
Published: (2010-06-01)

Benzoquinona e hidroquinona preniladas y otros constituyentes aislados de Piper Bogotense C. DC.
by: Luz Angela Peña, et al.
Published: (2010-11-01)

Exogenous ochronosis: case report and literature review Ocronose exógena: relato de caso e revisão de literatura
by: Viviane Maria Rocha Martins, et al.
Published: (2012-08-01)

Hidroxilación de fenol con catalizadores ZSM-5 modiﬁcado con cobre
by: César Augusto Caro, et al.
Published: (2005-01-01)

O lado negro dos clareadores cutâneos
by: Daniela Alves Pereira Antelo
Published: (2019-01-01)

Extrafacial melasma: A scenario less explored
by: Manju Daroach, et al.
Published: (2022-01-01)

Comparing Kojic Acid Cream 2% with Glycolic Acid 10% and Hydroquinone Cream 2% in Treatment of Melasma
by: Fariba Iraji, et al.
Published: (2014-03-01)

Queimaduras e suas cicatrizes
by: Leandra d’Orsi Metsavaht
Published: (2017-10-01)

Bioindicadores neotropicais de ecotoxicidade e risco ambiental de fármacos de interesse para aquicultura
by: Taise FLORÊ NCIO, et al.
Published: (2018-11-01)

Correlating impairment of quality of life and severity of melasma: A cross-sectional study of 141 patients
by: Preeti Kothari, et al.
Published: (2018-01-01)

REAÇÕES ADVERSAS RELACIONADAS À POLIMIXINA B EM PACIENTES ATENDIDOS EM UM HOSPITAL UNIVERSITÁRIO TERCIÁRIO DO PARANÁ
by: Francielly Palhano Gregorio, et al.
Published: (2023-10-01)

Efeitos da Heroína nos Parâmetros Eletrocardiográficos
by: Ersin Yildirim, et al.

Management of Melasma: Laser and Other Therapies—Review Study
by: Badea Jiryis, et al.
Published: (2024-03-01)

ASPECTS OF CURRENT RESEARCH ON MELASMA
by: Ana Maria Alexandra Stănescu, et al.
Published: (2019-12-01)

Newer botanicals in melasma: A review
by: Saloni Sawarthia, et al.
Published: (2023-01-01)

Unmasking dermoscopic evaluation of melasma: findings of a cross-sectional study in central India
by: Sahana Sreenath, et al.
Published: (2022-01-01)

Comparison of therapeutic efficacy of intralesional platelet-rich plasma and topical alpha-glucoside derivative of trihydroxy benzoic acid in melasma: a randomized controlled study
by: Milan Jhavar, et al.
Published: (2022-01-01)

Treatment Evaluation of Melasma Patients in Dr. Hasan Sadikin General Hospital Bandung in period of 2013–2014
by: Ayu Adzani Sabila, et al.
Published: (2016-12-01)

Melasma: A clinico-epidemiological study of 312 cases
by: Arun Achar, et al.
Published: (2011-01-01)

Evaluating the Effect of Atache Despigman Cream for the Treatment of Melasma
by: Farhad Handjnai, et al.
Published: (2022-12-01)

Comparative efficacy of 2% Hydroquinone and Melfade in Treatment of Melasma
by: R Yaghmaee, et al.
Published: (2011-04-01)

Eficacia de la combinación de dos técnicas no invasivas como alternativa terapéutica en casos con melasma
by: Blanca Barroeta, et al.
Published: (2021-12-01)

>A.S.A.P. - The first algorithm to treat keloids and hypertrophic scars
by: Gisele Viana Oliveira, et al.
Published: (2022-12-01)

The Relationship Between Sunscreen Application and Severity Of Melasma
by: Intan Annisa Putri, et al.
Published: (2022-08-01)

Quality of life scales in pigmentary disorders
by: Shikha Shah, et al.
Published: (2023-01-01)

A hospital-based cross-sectional study of clinical, wood's lamp, and dermoscopic findings in melasma
by: P M Amrutha Herle, et al.
Published: (2023-01-01)

Efficacy, effectiveness, and safety of combination laser and tranexamic acid treatment for melasma: A meta-analysis
by: Arika Latashia Adelia, et al.
Published: (2023-09-01)

A comparative study between the use of the combination of trichloroacetic acid peeling with hydroquinone and hydroquinone alone in patients with melasma
by: Sabina Adhikari, et al.
Published: (2023-06-01)

Cosmeceuticals in hyperpigmentary disorders
by: Subburaj Kiruthika, et al.
Published: (2023-01-01)

A study of dermoscopy in patients of melasma in a tertiary care centre in North India
by: Neerja Puri, et al.
Published: (2022-01-01)

A randomized controlled study comparing the efficacy of topical 5% tranexamic acid solution versus 3% hydroquinone cream in melasma
by: Manasa S Janney, et al.
Published: (2019-01-01)

Knowledge and attitude of general population toward effects of sun exposure and use of sunscreens
by: Shweta Bharat Agarwal, et al.
Published: (2018-01-01)

Correlation Between Glutathione Plasma with Degree Severity of Melasma in Balinese Women
by: Wiraguna AAGP, et al.
Published: (2020-07-01)

Exogenous Ochronosis
by: Prachi A Bhattar, et al.
Published: (2015-01-01)

Tranexamic acid in melasma: a review
by: Amrit Kaur, et al.
Published: (2020-01-01)

Comparison between the efficacy of 10% zinc sulfate solution with 4% hydroquinone cream on improvement of melasma
by: Fariba Iraji, et al.
Published: (2012-01-01)

A clinico-epidemiological study of facial melanosis at a tertiary care center in Gujarat
by: Pooja Agarwal, et al.
Published: (2019-01-01)

Melanogenesis Inhibitors
by: Sulekha Kumari, et al.
Published: (2018-08-01)